CN1686321A - 蚁参药酒 - Google Patents
蚁参药酒 Download PDFInfo
- Publication number
- CN1686321A CN1686321A CNA2005100461598A CN200510046159A CN1686321A CN 1686321 A CN1686321 A CN 1686321A CN A2005100461598 A CNA2005100461598 A CN A2005100461598A CN 200510046159 A CN200510046159 A CN 200510046159A CN 1686321 A CN1686321 A CN 1686321A
- Authority
- CN
- China
- Prior art keywords
- examples
- radix
- ant
- ginseng
- effective rate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 241000208340 Araliaceae Species 0.000 title claims abstract description 18
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 title claims abstract description 18
- 235000003140 Panax quinquefolius Nutrition 0.000 title claims abstract description 18
- 235000008434 ginseng Nutrition 0.000 title claims abstract description 18
- 241000222336 Ganoderma Species 0.000 claims abstract description 8
- 241001251068 Formica fusca Species 0.000 claims description 9
- 239000009636 Huang Qi Substances 0.000 claims description 7
- 239000002994 raw material Substances 0.000 claims description 5
- 210000004185 liver Anatomy 0.000 abstract description 11
- 210000003734 kidney Anatomy 0.000 abstract description 9
- 210000004369 blood Anatomy 0.000 abstract description 5
- 239000008280 blood Substances 0.000 abstract description 5
- 229940107666 astragalus root Drugs 0.000 abstract 1
- 230000007812 deficiency Effects 0.000 abstract 1
- 210000001503 joint Anatomy 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 43
- 201000010099 disease Diseases 0.000 description 23
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 23
- 208000024891 symptom Diseases 0.000 description 13
- 239000003814 drug Substances 0.000 description 9
- 208000011580 syndromic disease Diseases 0.000 description 9
- 239000007788 liquid Substances 0.000 description 7
- 238000000034 method Methods 0.000 description 6
- 238000005325 percolation Methods 0.000 description 6
- 230000001225 therapeutic effect Effects 0.000 description 6
- 208000006820 Arthralgia Diseases 0.000 description 5
- 208000002193 Pain Diseases 0.000 description 5
- 230000002950 deficient Effects 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 238000001914 filtration Methods 0.000 description 4
- 239000000796 flavoring agent Substances 0.000 description 4
- 235000019634 flavors Nutrition 0.000 description 4
- 206010020751 Hypersensitivity Diseases 0.000 description 3
- 208000026935 allergic disease Diseases 0.000 description 3
- 230000007815 allergy Effects 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 201000003068 rheumatic fever Diseases 0.000 description 3
- 206010003694 Atrophy Diseases 0.000 description 2
- 208000000857 Hepatic Insufficiency Diseases 0.000 description 2
- 208000032912 Local swelling Diseases 0.000 description 2
- 208000001647 Renal Insufficiency Diseases 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- 230000037444 atrophy Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 210000003414 extremity Anatomy 0.000 description 2
- 206010016256 fatigue Diseases 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 238000007710 freezing Methods 0.000 description 2
- 230000008014 freezing Effects 0.000 description 2
- 210000003127 knee Anatomy 0.000 description 2
- 238000012856 packing Methods 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 230000035935 pregnancy Effects 0.000 description 2
- 239000002002 slurry Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 206010063659 Aversion Diseases 0.000 description 1
- 108010074051 C-Reactive Protein Proteins 0.000 description 1
- 102100032752 C-reactive protein Human genes 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 208000028017 Psychotic disease Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 206010061372 Streptococcal infection Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 210000000593 adipose tissue white Anatomy 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000000550 effect on aging Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000002607 hemopoietic effect Effects 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 239000011505 plaster Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
组别 | 例数 | 显效例(%) | 有效例(%) | 无效例(%) | 总有效率(%) | P值 |
观察组对照组 | 10060 | 61(61)10(16.7) | 34(34)44(73.3) | 5(5)6(10) | 9590 | >0.05 |
症型 | 例数 | 显效例(%) | 有效例(%) | 无效例(%) | 总有效率(%) | P值 |
寒湿组络症肝肾两虚症 | 5050 | 27(54)34(68) | 20(40)14(28) | 3(6)2(4) | 9496 | >0.05 |
组别 | 例数 | 显效例(%) | 有效例(%) | 无效例(%) | 总有效率(%) |
<0.5年≥0.5年且<1年≥1年且<3年≥3年 | 5104738 | 5(100)9(100)31(66.0)16(42.1) | 1(10)16(34.0)17(44.7) | 5(13.2) | 10010010086.8 |
疗程 | 例数 | 显效例(%) | 有效例(%) | 无效例(%) | 总有效率(%) |
第一周第二周第三周第四周 | 100100100100 | 1(1)61(61) | 5(5)84(84)34(34) | 10095155 | 58595 |
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2005100461598A CN1274340C (zh) | 2005-03-29 | 2005-03-29 | 蚁参药酒 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2005100461598A CN1274340C (zh) | 2005-03-29 | 2005-03-29 | 蚁参药酒 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1686321A true CN1686321A (zh) | 2005-10-26 |
CN1274340C CN1274340C (zh) | 2006-09-13 |
Family
ID=35304363
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2005100461598A Expired - Fee Related CN1274340C (zh) | 2005-03-29 | 2005-03-29 | 蚁参药酒 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1274340C (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101798558A (zh) * | 2010-03-17 | 2010-08-11 | 东莞市天邦神叶食品有限公司 | 一种蚁参酒 |
CN102895348A (zh) * | 2012-11-08 | 2013-01-30 | 成都中医药大学 | 一种治疗风湿性关节疾病的药物组合物及制备方法和用途 |
CN107970326A (zh) * | 2018-01-22 | 2018-05-01 | 白山市金潮特产有限责任公司 | 一种复方大山蚁粉片及其制备方法 |
-
2005
- 2005-03-29 CN CNB2005100461598A patent/CN1274340C/zh not_active Expired - Fee Related
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101798558A (zh) * | 2010-03-17 | 2010-08-11 | 东莞市天邦神叶食品有限公司 | 一种蚁参酒 |
CN102895348A (zh) * | 2012-11-08 | 2013-01-30 | 成都中医药大学 | 一种治疗风湿性关节疾病的药物组合物及制备方法和用途 |
CN102895348B (zh) * | 2012-11-08 | 2014-07-30 | 成都中医药大学 | 一种治疗风湿性关节疾病的药物组合物及制备方法和用途 |
CN107970326A (zh) * | 2018-01-22 | 2018-05-01 | 白山市金潮特产有限责任公司 | 一种复方大山蚁粉片及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN1274340C (zh) | 2006-09-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1274340C (zh) | 蚁参药酒 | |
CN104491695A (zh) | 一种治疗黄褐斑的药物组合物 | |
CN1159050C (zh) | 一种治疗2型糖尿病的复方中药制剂 | |
CN106310040B (zh) | 一种治疗急性痛风性关节炎的中药组合物及其制备方法和应用 | |
CN115837065B (zh) | 一种中药组合物及其用途 | |
CN1698869A (zh) | 参百宁神口服液 | |
CN102727628B (zh) | 一种用于脐疗治疗功能性便秘或腹泻的中药组合物 | |
CN102488838A (zh) | 治疗病毒性心肌炎的中药组合物 | |
CN101628056B (zh) | 一种治疗糖尿病性便秘的合剂 | |
CN1879783A (zh) | 一种治疗糖尿病的药物 | |
CN101642485B (zh) | 一种含黄芪的药物组合物在制备治疗白细胞减少症、过敏性紫癜症的药物中的应用 | |
CN106581299B (zh) | 一种改善中老年肾气虚证的中药组合物及其应用 | |
CN101703660B (zh) | 一种抗衰老药物 | |
CN111529659A (zh) | 治疗缓慢性心律失常的中药组合物及其制备方法和应用 | |
CN1041494C (zh) | 用于治疗慢性缺血性心脏病的一种中药散剂胶囊 | |
CN1245197C (zh) | 治疗冠心病、病毒性心肌炎的中药制剂 | |
CN1245199C (zh) | 治疗糖尿病的口服药物组合物 | |
CN1872186A (zh) | 复方枣仁胶囊及其制备方法 | |
CN104689244A (zh) | 一种治疗心脾血虚型病毒性心肌炎的中药丸及制备方法 | |
CN104147317A (zh) | 一种治疗***的药剂 | |
CN1233416C (zh) | 一种治疗小儿消化不良的复方胃蛋白酶散剂及其制备方法 | |
CN1253188C (zh) | 一种治疗高血压的药物及其制备方法 | |
CN102727730B (zh) | 治疗男性不育的复方中药制剂及其制备方法 | |
CN106822764A (zh) | 用于治疗脾胃气虚所致白血病的中药复方制剂及制备方法 | |
CN1899480A (zh) | 一种能够改变2型糖尿病胰岛素抵抗与糖、脂代谢紊乱的中药制剂 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: LI DECHUN Free format text: FORMER OWNER: GE QIANG Effective date: 20110414 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 114014 NO. 19, SHUANGTAI ROAD, TIEXI DEVELOPMENT ZONE, ANSHAN CITY, LIAONING PROVINCE TO: 114014 NO. 19, SHUANGTAI ROAD, HIGH-TECH. INDUSTRIAL DEVELOPMENT ZONE (WEST ZONE), ANSHAN CITY, LIAONING PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20110414 Address after: 114014 No. 19, double Road, hi tech Industrial Development Zone, Anshan, Liaoning Patentee after: Li Dechun Address before: 114014, Shuang Lu 19, Tiexi Development Zone, Liaoning, Anshan Patentee before: Ge Qiang |
|
ASS | Succession or assignment of patent right |
Owner name: LIAONING LIANGXIN (GROUP) DEFENG PHARMACEUTICAL CO Free format text: FORMER OWNER: LI DECHUN Effective date: 20140102 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 114014 ANSHAN, LIAONING PROVINCE TO: 114018 ANSHAN, LIAONING PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20140102 Address after: 114018 in the West Liaoning province Anshan high tech Industrial Development Zone, double Station Road No. 19 Patentee after: Liaoning Liangxin (Group) Defeng Pharmaceutical Co.,Ltd. Address before: 114014 No. 19, double Road, hi tech Industrial Development Zone, Anshan, Liaoning Patentee before: Li Dechun |
|
ASS | Succession or assignment of patent right |
Owner name: SICHUAN TIANLIAN PHARMACEUTICAL CO., LTD. Free format text: FORMER OWNER: LIAONING LIANGXIN (GROUP) DEFENG PHARMACEUTICAL CO., LTD. Effective date: 20150409 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 114018 ANSHAN, LIAONING PROVINCE TO: 620036 MEISHAN, SICHUAN PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20150409 Address after: 620036 Sichuan New District Economic Development Zone of Meishan Province Patentee after: SICHUAN TIANLIAN PHARMACEUTICAL Co.,Ltd. Address before: 114018 in the West Liaoning province Anshan high tech Industrial Development Zone, double Station Road No. 19 Patentee before: Liaoning Liangxin (Group) Defeng Pharmaceutical Co.,Ltd. |
|
TR01 | Transfer of patent right |
Effective date of registration: 20170613 Address after: 620020 5 camphor Road, Meishan Economic Development Zone, Sichuan, China Patentee after: SICHUAN DEFENG PHARMACEUTICAL CO.,LTD. Address before: 620036 Sichuan New District Economic Development Zone of Meishan Province Patentee before: SICHUAN TIANLIAN PHARMACEUTICAL Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20060913 |